Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice
暂无分享,去创建一个
T. Wittmann | T. Molnár | V. Théodorou | H. Eutamene | L. Buéno | A. Ait-Belgnaoui | A. Rosztóczy | R. Róka | K. Gecse | M. Dabek | A. Annaházi
[1] V. Théodorou,et al. M1185 High Fecal Serine-Protease Activity in IBD Patients Triggers Alterations of Paracellular Permeability in Mice Colon Through Par 4 Receptor Activation , 2008 .
[2] A. Kawabata,et al. Gastrointestinal roles for proteinase‐activated receptors in health and disease , 2008, British journal of pharmacology.
[3] M. Steinhoff,et al. Protease-activated receptors: novel PARtners in innate immunity. , 2007, Trends in immunology.
[4] F. Nagy,et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] N. Fukazawa,et al. Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys. , 2007, The American journal of pathology.
[6] M. Steinhoff,et al. Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulation , 2007, British journal of pharmacology.
[7] Christine T. N. Pham,et al. Neutrophil serine proteases: specific regulators of inflammation , 2006, Nature Reviews Immunology.
[8] K. Sharkey,et al. Visceral sensation and colitis: inflammation and hypersensitivity do not always go hand in hand , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[9] M. Benson,et al. Rectal afferent hypersensitivity and compliance in irritable bowel syndrome: differences between diarrhoea-predominant and constipation-predominant subgroups , 2006, European journal of gastroenterology & hepatology.
[10] E. Lindström,et al. Effect of DSS‐induced colitis on visceral sensitivity to colorectal distension in mice , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[11] M. Hollenberg,et al. Neutrophils and the kallikrein–kinin system in proteinase‐activated receptor 4‐mediated inflammation in rodents , 2005, British journal of pharmacology.
[12] Emeran A. Mayer,et al. Differences in brain responses to visceral pain between patients with irritable bowel syndrome and ulcerative colitis , 2005, Pain.
[13] S. Vanner,et al. Inflammation‐induced hyperexcitability of nociceptive gastrointestinal DRG neurones: the role of voltage‐gated ion channels , 2005, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[14] F. Cerveró,et al. Understanding the signaling and transmission of visceral nociceptive events. , 2004, Journal of neurobiology.
[15] D. Santini,et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. , 2004, Gastroenterology.
[16] Jeom-Yong Kim,et al. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. , 2004, Journal of veterinary science.
[17] R. Spiller,et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. , 2003, Gastroenterology.
[18] K. Kinnally,et al. Neutrophil Cathepsin G Promotes Detachment-induced Cardiomyocyte Apoptosis via a Protease-activated Receptor-independent Mechanism* , 2003, Journal of Biological Chemistry.
[19] K. Muramoto,et al. Neutrophil Serine Proteinases Activate Human Nonepithelial Cells to Produce Inflammatory Cytokines Through Protease-Activated Receptor 21 , 2003, The Journal of Immunology.
[20] M. Hollenberg,et al. Proteinase-activated receptor-2 and human lung epithelial cells: disarming by neutrophil serine proteinases. , 2003, American journal of respiratory cell and molecular biology.
[21] M. Hollenberg,et al. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. , 2002, The Biochemical journal.
[22] Wangxue Chen,et al. Activation of the mucosal immune system in irritable bowel syndrome. , 2002, Gastroenterology.
[23] M. Hollenberg,et al. International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors , 2002, Pharmacological Reviews.
[24] B. Guiard,et al. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. , 2002, Gastroenterology.
[25] D. Zochodne,et al. Proteinase‐activated receptor‐1 agonists attenuate nociception in response to noxious stimuli , 2002, British journal of pharmacology.
[26] P. Pasricha,et al. Molecular cloning of the rat proteinase-activated receptor 4 (PAR4) , 2002, BMC Molecular Biology.
[27] M. Hollenberg,et al. Glycosylation and the activation of proteinase‐activated receptor 2 (PAR2) by human mast cell tryptase , 2001, British journal of pharmacology.
[28] L. Chang,et al. Perceptual responses in patients with inflammatory and functional bowel disease , 2000, Gut.
[29] D. Fuchs,et al. The role of psychological and biological factors in postinfective gut dysfunction , 2000, Gut.
[30] Scott R. Presnell,et al. Cloning and characterization of human protease-activated receptor 4. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[31] C. Bernstein,et al. Rectal afferent function in patients with inflammatory and functional intestinal disorders , 1996, PAIN®.
[32] E A Mayer,et al. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. , 1995, Gastroenterology.
[33] M. Delvaux,et al. Evaluation of colonic sensory thresholds in IBS patients using a barostat , 1994, Digestive Diseases and Sciences.
[34] Ami,et al. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.
[35] H. Hodgson,et al. Granulocyte migration in ulcerative colitis , 1985, European journal of clinical investigation.
[36] J. Ritchie. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome 1 , 1973, Gut.
[37] A. Papatsoris,et al. DYSFUNCTION , 1952 .
[38] N. Talley. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity , 2009 .